Counterfeit biomedical devices: international seizure to protect patents and public health
A Turin-based biotechnology company, Human Brain Wave, falls victim to counterfeiting: seizure of uncertified and health-threatening devices in Europe
An international investigation has led to the seizure of hundreds of counterfeit biomedical devices, marketed in violation of the intellectual property rights of a company in Candiolo, Turin, specialising in biotechnology. The operation, which took place in December, involved the legal and operational headquarters and warehouses of the companies involved, scattered across various European countries. The affair is part of a broader picture of patent counterfeiting and the marketing of devices that are unsafe for human health.
The protagonist in the affair is the company Human Brain Wave (Hbw), holder of the patent for the ‘Regenerate System’, an innovative technology that allows tissue and organ repair through stem cell grafts. This system, also used in survival kits supplied to Ukrainian troops and developed in cooperation with NATO, has been imitated and infringed by an international network, with the production of uncertified and health-threatening devices.
The investigation, initiated in 2021 after a complaint by Hbw itself, revealed that a Turkish company was producing and marketing a device, called Medicons-P, copied from Hbw’s patent. The production, carried out with the machinery of Ctsv Srl, was supported by an international distribution network involving an Irish company and markets in Russia, Turkey, Eastern Europe, Latin America and the United States.
As a result of the checks carried out, by order of the judge, the Guardia di Finanza seized the counterfeit biomedical devices at the end of December, which not only infringed Hbw’s patent, but also posed a serious risk to public health as they lacked medical certifications. Among the devices seized were tissue-dissolving machines, called ‘Medimachine’, ‘Medigraft’ and ‘Medicons’, and the technical documentation relating to their manufacture.
Armando Roggero, managing director of Ctsv and former partner of Hbw; Raymond Gerard Sinnott, legal representative of Syntec International Ltd.; Francesco Schittini, managing director of Emotec Srl; and doctor Alessandro Icardi, one of the founders of Hbw, are involved in the investigation. According to investigators, these individuals were part of a transnational criminal organisation dedicated to the manufacture and distribution of counterfeit devices without the necessary health certifications.
The defenders of Hbw, through the legal team of International Lawyers Associates, emphasise the importance of strengthening the protection of industrial patents and intellectual property, including at the international level, to ensure the protection of scientific heritage and public health.
THE LATEST NEWS
(Photo: © AndKronos)
-
News21 ore agoScontro stradale ad Acilia: morta una ragazza di 27 anni
-
Meteo19 ore agoAllerta meteo per ciclone in Italia: maltempo e neve in quattro regioni
-
Primo Piano15 ore agoAuto esplosa a Mosca, chi era l’ufficiale russo Sarvarov ucciso oggi
-
Primo Piano20 ore agoStrage di Bondi Beach, assalitori addestrati in Australia: 15 morti


